Advanced

AJNR - American Journal of Neuroradiology

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Groell, R. Articles by Genser, B. Search for Related Content PubMed PubMed Citation Articles by Groell, R. Articles by Genser, B.

American Journal of Neuroradiology 20:1732-1736 (10 1999)
© 1999 American Society of Neuroradiology

ARTICLE

Contrast-Enhanced Spiral CT of the Head and Neck: Comparison of Contrast Material Injection Rates

Reinhard Groell^,a, Peter Willfurth^a, Gottfried J. Schaffler^a, Ramona Mayer^a, Ferdinand Schmidt^a, Martin M. Uggowitzer^a, Manfred Tillich^a and Bernd Genser^a

^a From the Department of Radiology (R.G., P.W., G.J.S., R.M., F.S., M.M.U., M.T., B.G.), University Hospital Graz, Graz, Austria.

BACKGROUND AND PURPOSE: Contrast-enhanced spiral CT studies of the head and neck are performed frequently using contrast material volumes of approximately 30 g iodine and a scan delay of 30–45 seconds. Because little is known about the effects of contrast material injection rates on tissue enhancement, this was prospectively investigated in our study.

METHODS: Ninety-seven patients underwent spiral CT of the head and neck. Each patient was assigned randomly to one of four groups who received 100 mL of nonionic contrast material (300 mg I/mL) at different monophasic injection flow rates with 1.5, 2, 3, and 4 mL/s. Scanning started after a constant delay of 35 seconds. The attenuation of the carotid artery, jugular vein, and sternocleidomastoid muscle was measured over time and the attenuation of the submandibular and thyroid gland was evaluated. Vascular attenuation of at least 150 HU was considered to be sufficient.

RESULTS: The mean scan time was 33 ± 5 seconds. The study, using an injection rate of 2 mL/s, showed the longest time of sufficient overall (arterial and venous) vessel attenuation (27 ± 4 seconds, P .008). The injection flow rate did not influence significantly muscular attenuation (mean enhancement during scan time: 9 ± 7 HU). The 1.5 mL/s protocol showed the lowest attenuation values of the submandibular gland (81 ± 12 HU) and the highest attenuation values of the thyroid gland (164 ± 22 HU), but the attenuation of the thyroid gland was not statistically different from that revealed by the 2 mL/s protocol.

CONCLUSION: Using 100 mL of intravenous contrast material with 300 mg I/mL for spiral CT studies of the entire head and neck, the optimal injection flow is 2 mL/s, whereas lower flow rates resulted in insufficient venous enhancement.

This article has been cited by other articles:

				R. Groell, O. Doerfler, G. J. Schaffler, and W. Habermann Contrast-Enhanced Helical CT of the Head and Neck: Improved Conspicuity of Squamous Cell Carcinoma on Delayed Scans Am. J. Roentgenol., June 1, 2001; 176(6): 1571 - 1575. [Abstract] [Full Text] [PDF]

				L. E. Ginsberg Contrast-enhanced Spiral CT of the Head and Neck AJNR Am. J. Neuroradiol., July 1, 2000; 21(7): 1365 - 0. [Full Text] [PDF]